Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexFemale
Age22-40
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

The aim of this study is preliminary exploration of the effectiveness and duration of autologous decidual-like NK cells therapy in improving uterine NK cells dysfunction.

Eligibility criteria

Qualifiers

abnormal uterine NK cell function;

have one of the following medical history: unexplained recurrent spontaneous abortions (≥2 spontaneous abortions, including biochemical pregnancy), repeated implantation failure (failure of implantation of good-quality embryos in at least two IVF cycles), unexplained infertility, early-onset severe gestational hypertension or early-onset fetal growth restriction;

have clear fertility desires;

normal ovarian function or with frozen embryos;

Disqualifiers

using progesterone receptor modulator;

chromosomal karyotype abnormalities in one spouse;

severe endometriosis, uterine fibroids affecting the shape of the uterine cavity or the size of the whole uterus more than 2 and a half months of pregnancy, uterine malformation, uterine adhesion or thin endometrium;

uncontrolled autoimmune diseases;

Trial design

Treatments tested in this trial

  • autologous decidual-like NK cells

Treatment groups

14 Participants
are divided into 1 treatment group

Sponsors and collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

The University of Science and Technology of China

Collaborator